▶ 調査レポート

アプタマーの世界市場分析・規模・シェア・成長・動向・予測:材料別(核酸アプタマー、ペプチドアプタマー)、選択法別(SELEX法、その他)、用途別(研究、診断、治療)

• 英文タイトル:Aptamer Market (Material - Nucleic acid Aptamer, Peptide Aptamer; Selection Technique - SELEX Technique and Others; Application - Research, Diagnostics, Therapeutics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Transparency Market Researchが調査・発行した産業分析レポートです。アプタマーの世界市場分析・規模・シェア・成長・動向・予測:材料別(核酸アプタマー、ペプチドアプタマー)、選択法別(SELEX法、その他)、用途別(研究、診断、治療) / Aptamer Market (Material - Nucleic acid Aptamer, Peptide Aptamer; Selection Technique - SELEX Technique and Others; Application - Research, Diagnostics, Therapeutics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 / TPM-B04230資料のイメージです。• レポートコード:TPM-B04230
• 出版社/出版日:Transparency Market Research / 2018年3月
• レポート形態:英文、PDF、170ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Global Site License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、アプタマーの世界市場について調べ、アプタマーの世界規模、市場動向、市場環境、材料別(核酸アプタマー、ペプチドアプタマー)分析、選択法別(SELEX法、その他)分析、用途別(研究、診断、治療)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・アプタマーの世界市場動向
・アプタマーの世界市場環境
・アプタマーの世界市場規模
・アプタマーの世界市場規模:材料別(核酸アプタマー、ペプチドアプタマー)
・アプタマーの世界市場規模:選択法別(SELEX法、その他)
・アプタマーの世界市場規模:用途別(研究、診断、治療)
・アプタマーの世界市場:地域別市場規模・分析
・アプタマーの北米市場規模・予測
・アプタマーのアメリカ市場規模・予測
・アプタマーの中南米市場規模・予測
・アプタマーのヨーロッパ市場規模・予測
・アプタマーのアジア市場規模・予測
・アプタマーの日本市場規模・予測
・アプタマーの中国市場規模・予測
・アプタマーのインド市場規模・予測
・競争状況・関連企業情報

Global Aptamer Market: Overview

Aptamers are special class of molecules that combine the advantages of both low molecular weight and protein molecules. These molecules have attracted the attention of several researchers working in various areas of science ranging from medicine to analytical chemistry. Aptamers illustrate lock-and-key relationship between aptamer molecules and binding partners i.e., target molecules. The procedure commonly used for the selection of aptamers for a specific target molecule is known as SELEX process.

The global aptamer market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on material type, selection technique, application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global aptamer market.

Global Aptamer Market: Key Segments

Based on material type the global aptamer market is segmented into nucleic acid aptamer and peptide aptamer. The material type segments have been analyzed based on type of aptamer uses for different application in the region. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. According to application the global aptamer market is segmented into research, diagnostics, therapeutics and others. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Aptamer Market: Regional Outlook

Geographically, the global aptamer market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico and Rest of Latin America) and Rest of World. The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the aptamer market are include AM Biotech, Aptagen, LLC., Aptamer Group, Aptamer Sciences, Inc., Base Pair Biotechnologies, CD Genomics, NeoVentures Biotechnology Inc., NAXXON Pharma, Aptus Biotech, TriLink BioTechnologies, LLC., and Pfizer Inc. among others.

The global aptamer market has been segmented as follows:

Aptamer Market, by Material

Nucleic acid Aptamer
Peptide Aptamer
Aptamer Market, by Selection Technique

SELEX Technique
Others (MARAS, etc.)
Aptamer Market, by Application

Research
Diagnostics
Therapeutics
Others
Aptamer Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Rest of World

レポート目次

Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary : Global Aptamer Market

Chapter 4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.1.2. Industry Evolution / Developments
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Pipeline Analysis – Aptamer Market
4.4. Porter’s Five Force Representation
4.5. Global Aptamer Market Analysis and Forecasts, 2015-2025
4.5.1. Market Revenue Projection (US$ Mn)
4.5.2. Market Outlook
4.6. Key Trends

Chapter 5. Global Aptamer Market Analysis and Forecasts, By Material Type
5.1. Key Findings / Developments
5.2. Introduction & Definition
5.3. Market Value Forecast By Material Type, 2016–2025
5.3.1. Nucleic acid Aptamer
5.3.2. Peptide Aptamer
5.4. Market Attractiveness By Material Type

Chapter 6. Global Aptamer Market Analysis and Forecasts, By Selection Technique
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Market Value and Volume Forecast By Selection Technique, 2016–2025
6.3.1. SELEX Technique
6.3.2. Others
6.4. Market Attractiveness By Selection Technique

Chapter 7. Global Aptamer Market Analysis and Forecasts, By Application
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Market Value and Volume Forecast By Application, 2017–2025
7.3.1. Research
7.3.2. Diagnostics
7.3.3. Therapeutics
7.3.4. Others
7.4. Market Attractiveness By Application

Chapter 8. Global Aptamer Market Analysis and Forecasts, By Geography/Region
8.1. Geographical Representation
8.2. Market Value and Volume Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Rest of World
8.3. Market Attractiveness By Region
8.4. Key Trends

Chapter 9. North America Aptamer Market Analysis and Forecast
9.1. Market Value Forecast By Country , 2017–2025
9.1.1. U.S.
9.1.2. Canada
9.2. Market Value Forecast By Material Type, 2016–2025
9.3. Market Value Forecast By Selection Technique, 2016–2025
9.4. Market Value Forecast By Application, 2016-2025
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Material Type
9.5.3. By Selection Technique
9.5.4. By Application
9.6. Key Trends

Chapter 10. Europe Aptamer Market Analysis and Forecast
10.1. Market Value Forecast By Country , 2017–2025
10.1.1. Germany
10.1.2. France
10.1.3. U.K.
10.1.4. Spain
10.1.5. Italy
10.1.6. Rest of Europe
10.2. Market Value Forecast By Material Type, 2016–2025
10.3. Market Value Forecast By Selection Technique, 2016–2025
10.4. Market Value Forecast By Application, 2016-2025
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Material Type
10.5.3. By Selection Technique
10.5.4. By Application
10.6. Key Trends

Chapter 11. Asia Pacific Aptamer Market Analysis and Forecast
11.1. Market Value Forecast By Country , 2017–2025
11.1.1. China
11.1.2. Japan
11.1.3. India
11.1.4. Australia & New Zealand
11.1.5. Rest of APAC
11.2. Market Value Forecast By Material Type, 2016–2025
11.3. Market Value Forecast By Selection Technique, 2016–2025
11.4. Market Value Forecast By Application, 2016-2025
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Material Type
11.5.3. By Selection Technique
11.5.4. By Application
11.6. Key Trends

Chapter 12. Latin America Aptamer Market Analysis and Forecast
12.1. Market Value Forecast By Country, 2017–2025
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Rest of LATAM
12.2. Market Value Forecast By Material Type, 2016–2025
12.3. Market Value Forecast By Selection Technique, 2016–2025
12.4. Market Value Forecast By Application, 2016-2025
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Material Type
12.5.3. By Selection Technique
12.5.4. By Application
12.6. Key Trends

Chapter 13. Rest of World Aptamer Market Analysis and Forecast
13.1. Market Value Forecast By Material Type, 2016–2025
13.2. Market Value Forecast By Selection Technique, 2016–2025
13.3. Market Value Forecast By Application, 2016-2025
13.4. Market Attractiveness Analysis
13.4.1. By Material Type
13.4.2. By Selection Technique
13.4.3. By Application
13.5. Key Trends

Chapter 14. Competition Landscape
14.1. Competition Matrix
14.2. Company Profiles
14.2.1. AM Biotech. (HQ, Business Segments, Employee Strength)
14.2.1.1. Company Details
14.2.1.2. Company Description
14.2.1.3. Business Overview
14.2.1.4. SWOT Analysis
14.2.1.5. Financial Analysis
14.2.1.6. Strategic Overview
14.2.2. Aptagen, LLC. (HQ, Business Segments, Employee Strength)
14.2.2.1. Company Details
14.2.2.2. Company Description
14.2.2.3. Business Overview
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Aptamer Group (HQ, Business Segments, Employee Strength)
14.2.3.1. Company Details
14.2.3.2. Company Description
14.2.3.3. Business Overview
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Aptamer Science, Inc. (HQ, Business Segments, Employee Strength)
14.2.4.1. Company Details
14.2.4.2. Company Description
14.2.4.3. Business Overview
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. Pfizer Inc. (HQ, Business Segments, Employee Strength)
14.2.5.1. Company Details
14.2.5.2. Company Description
14.2.5.3. Business Overview
14.2.5.4. SWOT Analysis
14.2.5.5. Financial Analysis
14.2.5.6. Strategic Overview
14.2.6. Base Pair Biotechnologies (HQ, Business Segments, Employee Strength)
14.2.6.1. Company Details
14.2.6.2. Company Description
14.2.6.3. Business Overview
14.2.6.4. SWOT Analysis
14.2.6.5. Financial Analysis
14.2.6.6. Strategic Overview
14.2.7. CD Genomics (HQ, Business Segments, Employee Strength)
14.2.7.1. Company Details
14.2.7.2. Company Description
14.2.7.3. Business Overview
14.2.7.4. SWOT Analysis
14.2.7.5. Financial Analysis
14.2.7.6. Strategic Overview
14.2.8. NeoVentures Biotechnology Inc. (HQ, Business Segments, Employee Strength)
14.2.8.1. Company Details
14.2.8.2. Company Description
14.2.8.3. Business Overview
14.2.8.4. SWOT Analysis
14.2.8.5. Financial Analysis
14.2.8.6. Strategic Overview
14.2.9. NAXXON Pharma (HQ, Business Segments, Employee Strength)
14.2.9.1. Company Details
14.2.9.2. Company Description
14.2.9.3. Business Overview
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. Aptus Biotech (HQ, Business Segments, Employee Strength)
14.2.10.1. Company Details
14.2.10.2. Company Description
14.2.10.3. Business Overview
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
14.2.11. TriLink Bio Technologies, LLC (HQ, Business Segments, Employee Strength)
14.2.11.1. Company Details
14.2.11.2. Company Description
14.2.11.3. Business Overview
14.2.11.4. SWOT Analysis
14.2.11.5. Strategic Overview

List of Tables

Table 01: Revenue Share (A), 2016
Table 02: Revenue Share (B), 2016
Table 03: Aptamer Based Drugs Pipeline Analysis
Table 04: Global Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
Table 05: Global Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
Table 06: Global Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 07: Global Aptamer Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Aptamer Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
Table 10: North America Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
Table 11: North America Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 12: Europe Aptamer Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 13: Europe Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
Table 14: Europe Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
Table 15: Europe Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 16: Asia Pacific Aptamer Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Asia Pacific Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
Table 18: Asia Pacific Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
Table 19: Asia Pacific Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 20: Latin America Aptamer Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 21: Latin America Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
Table 22: Latin America Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
Table 23: Latin America Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 24: Rest of World Aptamer Market Size (US$ Mn) Forecast, by Material Type, 2015–2025
Table 25: Rest of World Aptamer Market Size (US$ Mn) Forecast, by Selection Technique, 2015–2025
Table 26: Rest of World Aptamer Market Size (US$ Mn) Forecast, by Application, 2015–2025